Insider Buying: TriMas Co. (NASDAQ:TRS) Director Acquires 2,500 Shares of Stock

TriMas Co. (NASDAQ:TRSGet Free Report) Director Jeffrey A. Fielkow purchased 2,500 shares of TriMas stock in a transaction on Friday, February 28th. The stock was bought at an average price of $20.78 per share, for a total transaction of $51,950.00. Following the completion of the acquisition, the director now owns 11,013 shares in the company, valued at $228,850.14. The trade was a 29.37 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

TriMas Stock Performance

Shares of NASDAQ:TRS opened at $20.96 on Tuesday. TriMas Co. has a 52 week low of $19.33 and a 52 week high of $28.51. The stock has a market capitalization of $850.39 million, a P/E ratio of 32.75 and a beta of 0.66. The firm has a fifty day simple moving average of $23.71 and a two-hundred day simple moving average of $25.10. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60.

TriMas Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 28th will be paid a $0.04 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.76%. TriMas’s payout ratio is currently 27.12%.

Hedge Funds Weigh In On TriMas

A number of institutional investors and hedge funds have recently made changes to their positions in TRS. Bank of America Corp DE grew its stake in shares of TriMas by 127.3% in the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock worth $86,400,000 after buying an additional 1,967,738 shares in the last quarter. Bellecapital International Ltd. purchased a new position in shares of TriMas in the 4th quarter worth $29,160,000. Impax Asset Management Group plc grew its stake in shares of TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock worth $10,467,000 after buying an additional 280,431 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of TriMas in the 4th quarter worth $6,698,000. Finally, Wellington Management Group LLP boosted its stake in shares of TriMas by 10.7% during the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after purchasing an additional 252,537 shares during the period. 99.42% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on TRS shares. BWS Financial reiterated a “buy” rating and issued a $40.00 price target on shares of TriMas in a report on Friday. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.

Check Out Our Latest Report on TRS

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

See Also

Insider Buying and Selling by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.